Hostname: page-component-8448b6f56d-42gr6 Total loading time: 0 Render date: 2024-04-16T05:14:18.494Z Has data issue: false hasContentIssue false

Letter to the Editor: Are older studies lost in database searches for systematic reviews?

Published online by Cambridge University Press:  27 November 2017

B. H. Jonsson*
Affiliation:
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
R. Winzer
Affiliation:
Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden
C. Gornitzki
Affiliation:
University Library, Karolinska Institutet, Stockholm, Sweden
*
Author for correspondence: B. H. Jonsson, E-mail: bo.jonsson@ki.se
Rights & Permissions [Opens in a new window]

Abstract

Type
Correspondence
Copyright
Copyright © Cambridge University Press 2017 

We appreciate that Firth and colleagues undertook writing a systematic review on nutritional interventions for schizophrenia (Firth et al. Reference Firth, Stubbs, Sarris, Rosenbaum, Teasdale, Berk and Yung2017). Our concern is finding all relevant original studies for a systematic review.

The paper claims electronic searches were made for several databases from inception to July 2016. After identification, screening and assessment for eligibility, 18 studies were included, the oldest from 1990.

As database searches were not restricted to certain years, we notice that some papers published before 1990, which probably fulfilled the authors’ criteria were not included. Thus, we are interested if there may be relevant studies not identified in the data extraction process. We find the search words in Supplement 1 highly relevant, but the full search strategy is not described. As the reader is not informed which studies were excluded, providing an extensive search strategy would have facilitated replications of the search.

We found two reviews with a focus comparable with the Firth review. In 1991 a paper (Kleijnen & Knipschild, Reference Kleijnen and Knipschild1991) reviewed controlled trials of the vitamins B3 and B6 in mental disorders. For schizophrenia 17 trials in adults, published between 1955 and 1978, were included. Nine studies were described as randomized controlled trials and double-blinded (Hoffer et al. Reference Hoffer, Osmond, Callbeck and Kahan1957; Hoffer, Reference Hoffer1962; Ramsay et al. Reference Ramsay, Ban, Lehman, Saxena and Bennet1970; Ananth et al. Reference Ananth, Vacaflor, Kekhwa, Sterlin and Ban1972; Reference Ananth, Ban and Lehmann1973; McGrath et al. Reference McGrath, O'Brien, Power and Shea1972; Altman et al. Reference Altman, Mehta, Evenson and Sletten1973; Wittenborn et al. Reference Wittenborn, Weber and Brown1973; Deutsch et al. Reference Deutsch, Ananth and Ban1977). However, one reference (Hoffer, Reference Hoffer1962) is a book and may not have been eligible for the Firth review. We are concerned whether the other eight original publications, were excluded or not identified, respectively, in the Firth paper.

In 2011 a systematic review (Smedslund & Berg, Reference Smedslund and Berg2011) included 22 studies from 1957 to 2006 with vitamin interventions. Eight of these were the papers referred above from the Kleijnen review. Four studies were not included in the reviews by Firth or Kleijnen. Two of these were indexed in PubMed (Lohr & Caligiuri, Reference Lohr and Caligiuri1996; Vaughan & McCohagny, Reference Vaughan and McCohagny1999), and two were found in Google Scholar (Joshi & Eswaran, Reference Joshi and Eswaran1980; Lerner & Miodownik, Reference Lerner and Miodownik2007).

Thus, we found 12 studies included by Smedslund but not by Firth. Inclusion of any of these original studies may or may not have had implications for the main results. However, to be able to draw sound conclusions on the body of evidence, all relevant original studies meeting a review's criteria have to be retrieved and included in a systematic review. Otherwise, results may be incomplete or false.

Even if librarians or information specialists participate in database searching, as recommended (Higgins & Green, Reference Higgins and Green2008), older studies may not be found for different reasons. Database indexing may be incorrect or non-existent and papers may lack abstract. However, studies should not be discarded because of their age. Systematic reviews are becoming increasingly common, and maintaining a high quality is important.

References

Altman, H, Mehta, D, Evenson, RC and Sletten, IW (1973) Behavioral effects of drug therapy on psychogeriatric inpatients. II. Multivitamin supplement. Journal of the American Geriatrics Society 21, 249252.Google Scholar
Ananth, JV, Ban, TA and Lehmann, HE (1973) Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics. Canadian Psychiatric Association Journal 18, 377383.Google Scholar
Ananth, JV, Vacaflor, L, Kekhwa, G, Sterlin, C and Ban, TA (1972) Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study. International Journal of Clinical Pharmacology and Therapeutics 5, 406410.Google Scholar
Deutsch, M, Ananth, JV and Ban, TA (1977) Nicotinic acid in the treatment of chronic hospitalized schizophrenic patients: a placebo controlled clinical study. Psychopharmacology Bulletin 13, 2123.Google ScholarPubMed
Firth, J, Stubbs, B, Sarris, J, Rosenbaum, S, Teasdale, S, Berk, M and Yung, AR (2017) The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis. Psychological Medicine 9, 15151527.Google Scholar
Higgins, J and Green, S (2008) Cochrane Handbook for Systematic Reviews of Interventions. Chichester: Wiley.Google Scholar
Hoffer, A (1962) Niacin Therapy in Psychiatry. Springfield: Charles C Thomas.Google Scholar
Hoffer, A, Osmond, H, Callbeck, MJ and Kahan, I (1957) Treatment of schizophrenia with nicotinic acid and nicotinamide. Journal of Clinical and Experimental Psychopathology 18, 131158.Google Scholar
Joshi, VG and Eswaran, S (1980) Vitamins B1, B6, and B12 in the adjunctive treatment of schizophrenia. Journal of Orthomolecular Psychiatry 9, 3540.Google Scholar
Kleijnen, J and Knipschild, P (1991) Niacin and vitamin B6 in mental functioning: a review of controlled trials in humans. Biological Psychiatry 29, 931941.Google Scholar
Lerner, V and Miodownik, C (2007) Vitamin B6 – The Experience in Treating Psychotic Symptoms and Psychotropic Drug-Induced Movement Disorders. New York: Nova Science publishers.Google Scholar
Lohr, JB and Caligiuri, MP (1996) A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. Journal of Clinical Psychiatry 57, 167173.Google Scholar
McGrath, SD, O'Brien, PF, Power, PJ and Shea, JR (1972) Nicotinamide treatment of schizophrenia. Schizophrenia Bulletin 5, 7476.Google Scholar
Ramsay, RA, Ban, TA, Lehman, HE, Saxena, BM and Bennet, J (1970) Nicotinic acid as an adjuvant therapy in newly admitted schizophrenic patients. Canadian Medical Association Journal 102, 939942.Google ScholarPubMed
Smedslund, G and Berg, RC (2011) Effects of Vitamins, Fatty Acids, Minerals, and Other Dietary Supplements on Schizophrenic Symptoms in People with Schizophrenia. Report from Norwegian Knowledge Centre for the Health Services (NOKC) No. 19-2011. Oslo: Norwegian Knowledge Centre for the Health Services.Google ScholarPubMed
Vaughan, K and McCohagny, N (1999) Megavitamin and dietary treatment in schizophrenia: a randomized, controlled trial. Australian and New Zealand Journal of Psychiatry 33, 8488.CrossRefGoogle Scholar
Wittenborn, JR, Weber, ESP and Brown, M (1973) Niacin in the long-term treatment of schizophrenia. Archives of General Psychiatry 28, 308315.Google Scholar